April 1, 2011European Journal of Cardio-Thoracic Surgery
Surgical results of active infective native mitral valve endocarditis: repair versus replacement
Why the study?
Does mitral valve repair improve the composite of cardiac death and cardiac-related morbidities compared to mitral valve replacement in patients with active infective native mitral valve endocarditis?
Population
102 patients with active infective endocarditis involving only the native mitral valve. Mean age 34.4 ± 16.9…
Comparison
Mitral valve repair (MVP) vs Mitral valve replacement (MVR)
Design
Cohort
Follow-up
median 4.7 years (range, 0.1-15.8)
Authors
Discussion
Loading...
Member takes
Implication
Repair and replacement yield similar event-free survival; leaves open optimal strategy in randomized trials for active mitral endocarditis.
Structured PICO
Does mitral valve repair improve the composite of cardiac death and cardiac-related morbidities compared to mitral valve replacement in patients with active infective native mitral valve endocarditis?
P
Population
102 patients with active infective endocarditis involving only the native mitral valve. Mean age 34.4 ± 16.9 years in the MVP group and 43.1 ± 14.9 years in the MVR group.
I
Intervention
Mitral valve repair (MVP)
C
Comparator
Mitral valve replacement (MVR)
O
Outcome
Composite end points of cardiac death and cardiac-related morbiditiescomposite
In patients with active infective native mitral valve endocarditis, mitral valve repair and replacement yield similar long-term survival and event-free survival.
Cite This Study
Jung et al. (2011) studied this question.